Cantitate/Preț
Produs

Experimenting with the Consumer: The Mass Testing of Risky Products on the American Public

Autor Marshall S. Shapo
en Limba Engleză Hardback – 30 dec 2008
Experimenting With The Consumer exposes the hazards of the mass-market experimentation in which every American consumer and worker is unwittingly tapped for product risk data by manufacturers, scientists, and regulators. Vioxx, Heparin, Avandia, Paxil, fen-phen, estrogens, silicone implants, pacemakers, formaldehyde in FEMA trailers, 60 buckyballs in coatings . the headlines are increasingly filled with hidden risks coming to light in popular products years after federal agencies approve them for the American public. Shapo shows readers how to get past unreasonable trust or fear and make the best risk-management choices for themselves and their families. He walks them through what questions to ask before consenting to be in a clinical trial; how to evaluate the implied bold-print claims against the small-print disclosures in advertisements for medical products; how to uncover product and environmental risks in their homes, workplaces, supermarkets, and neighborhoods; how to assess and control product risk while maximizing consumer choice and benefit; how to pressure government to tighten consumer protection; and how to seek legal redress.

Through a diverse selection of dramatic case studies, Shapo lays bare the incentives of companies and entrepreneurial scientists to fake or obscure experimental data before and after government approval; the fights between interested and disinterested scientists over data; the fights between scientists and doctors over patient rights; the campaigns of activists against government agencies to release experimental drugs; the impact of the journalistic and promotional media on public knowledge and perception of product risk; and the marketing tricks that manufacturers use to harness sexual desire to product launches and to shape the prescription choices of physicians.
Citește tot Restrânge

Preț: 29488 lei

Preț vechi: 37751 lei
-22%

Puncte Express: 442

Preț estimativ în valută:
5217 6065$ 4522£

Carte tipărită la comandă

Livrare economică 04-18 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780313365287
ISBN-10: 0313365288
Pagini: 304
Dimensiuni: 156 x 235 x 30 mm
Greutate: 0.45 kg
Editura: Bloomsbury Publishing
Colecția Praeger
Locul publicării:New York, United States

Cuprins

INTRODUCTION
Chapter One: EXPERIMENTATION: A SURVEY AT TRENCH LEVEL
Chapter Two: HIV/AIDS DRUGS: SPEEDING UP SCIENCE, UNDER
POLITICAL PRESSURE
Chapter Three: BREAST IMPLANTS: A PARABLE OF LAWS
RESPONSE TO IMPROVEMENTS ON NATURE
Chapter Four: TREATING THYSELFFOR MEN ONLY: VIAGRA
Chapter Five: ESTROGENSA GATHERING OF DATA, A
G
ATHERING STORM
Chapter Six: ESTROGENSTHE STORM BREAKS; A STRUGGLE
OF MEDICINE, LAW, AND POLITICS
Chapter Seven: EXPERIMENTS AT THE BILLION LEVEL
:NANOTECHNOLOGY
CONCLUSION

Recenzii

HIV/AIDS drugs, breast implants, Viagra, estrogen, and nanotechnology are the examples Shapo (law, Northwestern U.) describes in detail, but he selected them from a great number of cases in which corporations profited by selling products that they knew were risky but that consumers did not. He concludes with advice for consumers and suggestions for policy changes.
Recommended. All readership levels.
I would recommend Experimenting with the Consumer to members of both the plaintiff bar and the public. As Shapo states, we should not be afraid after reading the revelations in this book; rather, we should all be alittle more sensible.
The book is extremely well referenced and scholarly. The author clearly and faithfully shows the tremendous pressure and expectations that the public can bring to federal agencies and manufacturers for treatments ranging from life threatening diseases (HIV/AIDS) to those that improve quality of life (Viagra, Premarin, Prempro). . . . Although the title of this book is one designed to attract attention, inside is a deep and thoughtful discussion of the systems in place-- regulatory, legal, scientific, and ethical--that balance the risks and benefits of products for the American public in an ongoing, dynamic way.